Krka nine-month profit down 40% to EUR 80.3m

Novo Mesto, 17 November - Pharma group Krka reported on Thursday a nine-month net profit of EUR 80.3m, which is a 40% drop year-on-year that came as sales revenues decreased by 1% to EUR 852.4m. Krka attributes the result to lower drug prices and the devaluation of certain Eastern European currencies, especially the rouble.